Reduction of ER-MAM-localized APP-C99 and methods of treating alzheimer's disease Grant US-11266626-B2 United States of America 08 Mar 2022
Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic… Grant US-11020360-B2 United States of America 01 Jun 2021
Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic… Grant US-10857109-B2 United States of America 08 Dec 2020
Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic… Grant US-10238611-B2 United States of America 26 Mar 2019
GAMMA-SECRETASE STABILIZING COMPOUND SCREENING ASSAY Application WO-2018130555-A1 World Intellectual Property Organisation (WIPO) 19 Jul 2018
Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic… Grant US-9499480-B2 United States of America 22 Nov 2016
Methods for screening to identify therapeutic agents for Alzheimer's disease and use… Grant US-9265735-B2 United States of America 23 Feb 2016
Use of selenium compounds, especially selenium yeasts for altering cognitive function Grant US-8871715-B2 United States of America 28 Oct 2014
Methods and compositions for altering cell function Grant US-8865763-B2 United States of America 21 Oct 2014
Method and compositions for treating amyloid-related diseases Grant US-8835654-B2 United States of America 16 Sep 2014
Treatment of amyloidoses using myelin basic protein and fragments thereof Grant US-8815794-B2 United States of America 26 Aug 2014
Treatment of glycogen synthase kinase-based disease Grant US-8778986-B1 United States of America 15 Jul 2014
Method for diagnosing alzheimer's disease using serum glycoprotein as biomarker Grant US-8609346-B2 United States of America 17 Dec 2013
MEANS AND METHOD FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE Application WO-2013113696-A1 World Intellectual Property Organisation (WIPO) 08 Aug 2013
(3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide… Grant US-8299267-B2 United States of America 30 Oct 2012
CLEAVAGE INHIBITORS OF TRANSFORMING GROWTH FACTOR BETA TYPE I RECEPTOR AND USES THEREOF… Application WO-2012125623-A2 World Intellectual Property Organisation (WIPO) 20 Sep 2012
Fused, tricyclic sulfonamide inhibitors of gamma secretase Application EP-2450358-A1 European Patent Office 09 May 2012
Presenilin associated membrane protein (PAMP) and uses thereof Grant US-8067224-B2 United States of America 29 Nov 2011
Methods and compositions for treating amyloid-related diseases Grant US-8044100-B2 United States of America 25 Oct 2011
METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS Application US-20110256565-A1 United States of America 20 Oct 2011
Catalytically active recombinant memapsin and methods of use thereof Grant US-7829669-B2 United States of America 09 Nov 2010
Hydroxyethylene-based β-secretase inhibitors and use thereof Grant US-7659289-B2 United States of America 09 Feb 2010
Compounds which inhibit beta-secretase activity and methods of use Grant US-7504420-B2 United States of America 17 Mar 2009
Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease Grant US-7378111-B2 United States of America 27 May 2008
Selectively inhibit memapsin 2 beta -secretase activity relative to memapsin 1 beta -secret… Grant US-7335632-B2 United States of America 26 Feb 2008
GREEN TEA POLYPHENOL ALPHA SECRETASE ENHANCERS AND METHODS OF USE Application WO-2006116535-A1 World Intellectual Property Organisation (WIPO) 02 Nov 2006
Gene-targeted non-human mammal with human fad presenilin mutation and generational… Grant US-6734336-B1 United States of America 11 May 2004
PEPTIDES DERIVED FROM CADHERIN AND METHODS OF USE THEREOF Application WO-2003087136-A2 World Intellectual Property Organisation (WIPO) 23 Oct 2003